why choose us

Clinical Trials Search

Showing 19,350 of 132,963 result(s)
HIV and Alcohol Research Center Focused on Polypharmacy (HARP)

Status: Completed

Condition: HIV

Interventions: The clinical pharmacist will employ MI in informational, participant-centered discussions in which the clinical pharmacist and participant collaborati

Date: 2022-09-26

A Study of Iberdomide (CC-220) in Combination With Elotuzumab and Dexamethasone for Relapsed;Refractory Multiple Myeloma

Status: Completed

Condition: Multiple Myeloma

Interventions: Route of administration: oral pill.
Schedule: Taken Once daily on days 1-21.
Dose: will be tested at 1 mg, 1.3 mg, and 1.6mg.
1mg dose

Date: 2022-09-26

A Regional Partnership to Improve Outcomes Through Fatherhood Engagement

Status: Completed

Condition: Substance Use

Interventions: To encourage intrinsic motivation to engage in fatherhood activities

Date: 2022-09-26

CMV CTLs in Neonates With CMV Infection

Status: Completed

Condition: Congenital Cytomegaloviral (CMV) Disease

Interventions: Patients will receive maternal CMV CTLs on day 0. Additional doses of CMV CTLs may be re-infused at a minimum of every two weeks for a maximum of five

Date: 2022-09-26

Variation of Atelectasis Score After High-frequency Percussions in Severe Acquired Brain Injury

Status: Completed

Condition: Atelectasis
Acquired Brain Injury
Respiratory Rehabilitation

Interventions: Device: Treatment with Metaneb®
Every patient of this group receive 3 daily treatments of 20 minutes each, performed at approximately 4-hour inte

Date: 2022-09-26

Long-term Follow-up on Childhood Adiposity - The FitKids Study

Status: Completed

Condition: Child Obesity

Interventions:

Date: 2022-09-26

Intraoperative Clonidine for Postoperative Pain Management in Patients Undergoing Surgical Treatment for Endometriosis

Status: COMPLETED

Condition: Endometriosis

Interventions: A single dose of intraoperatively administered intravenous clonidine 150 ?g will be infused over 5-10 min., immediately after intubation

Date: 2022-09-26

Safety of the Herpes Zoster Subunit Vaccine in Lupus

Status: NOT_YET_RECRUITING

Condition: Systemic Lupus Erythematosus

Interventions: Manufactured by GSK Biologicals SA.
Administered as two-time injection of 0.5 mL each at either weeks 0 and 8 or weeks 24 and 32.

Date: 2022-09-26

Healing Opioid Misuse and Pain Through Engagement (HOPE) Trial

Status: Completed

Condition: Opioid Use Disorder

Interventions: This intervention is an integrated psychosocial treatment of two established treatments for chronic pain and Opioid Use Disorder (OUD).
This inte

Date: 2022-09-26

Patient-centered Goal Setting in the National Diabetes Prevention Program

Status: Completed

Condition: PreDiabetes

Interventions: NDPP + patient-centered goal setting

Date: 2022-09-26